BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 6486125)

  • 1. Cellular actions and pharmacology of the calcium channel blocking drugs.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Med; 1984 Aug; 77(2B):2-10. PubMed ID: 6486125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular actions and pharmacology of calcium-channel blockers.
    Katz AM; Hager WD; Messineo FC; Pappano AJ
    Am J Emerg Med; 1985 Dec; 3(6 Suppl):1-9. PubMed ID: 4084378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology and mechanisms of action of calcium-channel blockers.
    Katz AM
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):28S-37S. PubMed ID: 3540226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of calcium antagonists on myocardial and smooth muscle membranes.
    Zakhari S
    Drugs Exp Clin Res; 1986; 12(9-10):817-29. PubMed ID: 3539569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review.
    Opie LH
    Q J Med; 1984; 53(209):1-16. PubMed ID: 6324268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium channel blockers (calcium antagonists). Background, effects and use].
    Mikkelsen EO
    Ugeskr Laeger; 1995 Jun; 157(26):3750-4. PubMed ID: 7631450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists. Some chemical-pharmacologic aspects.
    Triggle DJ; Swamy VC
    Circ Res; 1983 Feb; 52(2 Pt 2):I17-28. PubMed ID: 6299605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hypertension and calcium-channel blockers.
    Kanneganti M; Halpern NA
    New Horiz; 1996 Feb; 4(1):19-25. PubMed ID: 8689271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel diversity in the cardiovascular system.
    Katz AM
    J Am Coll Cardiol; 1996 Aug; 28(2):522-9. PubMed ID: 8800134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 13. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-channel blockers and systemic hypertension.
    Frishman WH; Charlap S; Ocken S; Spivack C
    J Clin Hypertens; 1985 Jun; 1(2):107-22. PubMed ID: 3915318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers.
    Deedwania PC
    West J Med; 1982 Jul; 137(1):24-31. PubMed ID: 6291255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the calcium channel blockers.
    Stone KS; Scordo KA
    Heart Lung; 1984 Sep; 13(5):563-73. PubMed ID: 6088433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium channel blockers for the treatment of coronary artery spasm: rationale, effects, and nursing responsibilities.
    Braun LT
    Heart Lung; 1983 May; 12(3):226-32. PubMed ID: 6551368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.